10.21-10.27 | 临床研究顶刊快报
文摘
教育
2024-10-28 10:08
中国香港
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
1. Solomon SD, McMurray JJV, Vaduganathan M, Claggett B, Jhund PS, Desai AS, et al. Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. New England Journal of Medicine. 2024;391(16):1475-85.2. Cho BC, Lu S, Felip E, Spira AI, Girard N, Lee J-S, et al. Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC. New England Journal of Medicine. 2024;391(16):1486-98.3. Dias J, Tharmanathan P, Arundel C, Welch C, Wu Q, Leighton P, et al. Collagenase Injection versus Limited Fasciectomy for Dupuytren’s Contracture. New England Journal of Medicine. 2024;391(16):1499-510.4. Ganesh VS, Riquin K, Chatron N, Yoon E, Lamar K-M, Aziz MC, et al. Neurodevelopmental Disorder Caused by Deletion of CHASERR, a lncRNA Gene. New England Journal of Medicine. 2024;391(16):1511-8.5. Pinkerton JV, Simon JA, Joffe H, Maki PM, Nappi RE, Panay N, et al. Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: OASIS 1 and 2 Randomized Clinical Trials. JAMA. 2024;332(16):1343-54.6. Investigators TWCftT, Investigators T. Thrombectomy for Stroke With Large Infarct on Noncontrast CT: The TESLA Randomized Clinical Trial. JAMA. 2024;332(16):1355-66.7. Semenzato L, Le Vu S, Botton J, Bertrand M, Jabagi M-J, Drouin J, et al. Long-Term Prognosis of Patients With Myocarditis Attributed to COVID-19 mRNA Vaccination, SARS-CoV-2 Infection, or Conventional Etiologies. JAMA. 2024;332(16):1367-77.8. The effect of tranexamic acid on postpartum bleeding in women with moderate and severe anaemia (WOMAN-2): an international, randomised, double-blind, placebo-controlled trial. The Lancet. 2024;404(10463):1645-56.9. Ker K, Sentilhes L, Shakur-Still H, Madar H, Deneux-Tharaux C, Saade G, et al. Tranexamic acid for postpartum bleeding: a systematic review and individual patient data meta-analysis of randomised controlled trials. The Lancet. 2024;404(10463):1657-67.10. Wu X, Sun Y, Yang H, Wang J, Lou H, Li D, et al. Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China. The Lancet. 2024;404(10463):1668-76.11. Lee W, Kang C, Park C, Bell ML, Armstrong B, Roye D, et al. Association of holidays and the day of the week with suicide risk: multicounty, two stage, time series study. BMJ. 2024;387:e077262.12. He M, Jiang Y-Z, Gong Y, Fan L, Liu X-Y, Liu Y, et al. Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trial. BMJ. 2024;387:e079603.13. Alkabbani W, Suissa K, Gu KD, Cromer SJ, Paik JM, Bykov K, et al. Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study. BMJ. 2024;387:e080340.部分文字参考新英格兰医学前沿。
